PRC
BIO icon

Pearl River Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pearl River Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-853
Closed -$233K – 49
2024
Q2 		$233K Sell
853
-657
-44% -$191K 0.04% 382
2024
Q1 		$522K Sell
1,510
-1,420
-48% -$467K 0.08% 299
2023
Q4 		$946K Buy
+2,930
New +$918K 0.15% 211
2020
Q1 		– Sell
-2,060
Closed -$762K – 518
2019
Q4 		$762K Buy
+2,060
New +$726K 0.28% 99

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pearl River Capital's BIO Position: Q3 2024 in Review

Pearl River Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 853 shares — an estimated $233K sold.

Pearl River Capital first reported a position in BIO in Q4 2019 and held it in 4 quarters. The position peaked at $946K in Q4 2023. 437 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Pearl River Capital reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Pearl River Capital sold 853 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $233K.
  • Pearl River Capital first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 4 quarters.
  • Pearl River Capital's Bio-Rad Laboratories Class A position peaked at $946K in Q4 2023.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.